The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 12, 2023

Filed:

Jun. 11, 2018
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Minnie Sarwal, San Francisco, CA (US);

Marina Sirota, Belmont, CA (US);

Silvia Pineda San Juan, Madrid, ES;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); G01N 33/50 (2006.01); C12Q 1/6851 (2018.01); G01N 33/564 (2006.01); C12Q 1/6883 (2018.01); G01N 33/68 (2006.01); G16B 5/20 (2019.01); G16B 5/00 (2019.01);
U.S. Cl.
CPC ...
G01N 33/5094 (2013.01); C12Q 1/6851 (2013.01); C12Q 1/6883 (2013.01); G01N 33/564 (2013.01); G01N 33/6854 (2013.01); G16B 5/20 (2019.02); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01); G01N 33/505 (2013.01); G01N 33/5052 (2013.01); G01N 2333/70503 (2013.01); G01N 2800/245 (2013.01); G16B 5/00 (2019.02);
Abstract

Methods of assessing a graft recipient's predisposition to reject a transplant are provided. The risk of transplant rejection may be assessed in a subject prior to transplant, wherein subjects having a greater immune repertoire diversity prior to transplant are more susceptible to transplant rejection. Also, increases in immune repertoire diversity after transplant are indicative of transplant risk after. In another aspect, the presence or elevated abundance of immune elements comprising IGHV3-23 sequences are indicators of transplant rejection risk. In another aspect the scope of the invention encompasses methods of treating transplant rejection in a subject, by assessing transplant risk and administering immunosuppressive therapy in accordance with assessed risk.


Find Patent Forward Citations

Loading…